Peptide wellness — educational product library
Explore the current peptide science, evidence limitations, safety context, and regulatory considerations for each topic. American-sourced quality standards inform every product we feature.
Evidence contextBPC-157 + TB-500 + GHK-Cu
An educational overview of a three-peptide combination discussed in regenerative and aesthetic research. Human evidence, safety, product quality, and regulatory context should be evaluated for each peptide component individually.
Educational overview
Research topic
Evidence contextGrowth Hormone-Releasing Hormone Analog
A shorter-acting synthetic GHRH-related peptide. Human clinical evidence specifically evaluating the No DAC form remains limited. Peptide quality and American-sourced manufacturing standards are key considerations.
Educational overview
Research topic
Preclinical focusEmerging Peptide Research
A 15-amino-acid synthetic peptide with laboratory and animal research across tissue response, gastrointestinal biology, and inflammatory processes. One of the most studied peptides in preclinical research.
Educational overview
Research topic
Research focusLysine-Proline-Valine | Emerging Peptide Research
A three-amino-acid sequence related to α-MSH, studied in laboratory and preclinical models of inflammatory and immune-related signaling.
Educational overview
Research topic
Evidence contextThymosin Beta-4 Fragment | Emerging Peptide Research
A synthetic seven-amino-acid fragment related to thymosin beta-4. Evidence specifically involving TB-500 in humans is extremely limited.
Educational overview
Research topic
Route mattersCopper-Binding Tripeptide | Skin & Tissue Research
A naturally occurring copper-binding tripeptide studied in skin, extracellular-matrix, and tissue biology. Route of administration matters when evaluating evidence.
Educational overview
Research topic
Clinical historyGrowth Hormone-Releasing Hormone Analog | GHRH (1-29)
A synthetic GHRH (1-29) peptide with a longer history of human research than many emerging peptides. Current compounded preparations are not FDA approved.
Educational overview
Research topic
Evidence contextGrowth Hormone Secretagogue | Emerging Peptide Research
A five-amino-acid growth hormone secretagogue studied in human research, including gastrointestinal motility and postoperative ileus contexts.
Educational overview
Research topic
Metabolic researchMitochondrial-Derived Peptide | Emerging Metabolic Research
A naturally occurring mitochondrial-derived peptide studied in cellular metabolism, exercise-related signaling, and metabolic stress responses.
Educational overview
Research topic
Research contextHuman Growth Hormone Fragment | Metabolic Research
A synthetic fragment derived from human growth hormone that was investigated in metabolic and obesity research. It is not an FDA-approved medication.
Educational overview
Research topic
Cellular biologyNicotinamide Adenine Dinucleotide | Cellular Energy & Metabolic Research
A naturally occurring coenzyme, not a peptide, with essential roles in cellular energy metabolism, mitochondrial function, and DNA-repair pathways.
Educational overview
Research topic
Clinical researchThymosin Alpha-1 | Immune-System Research
A 28-amino-acid peptide with a substantial history of human clinical investigation across immune-system research. Evidence quality varies by application.
Educational overview
Research topic
Safety contextBremelanotide | Melanocortin Receptor Agonist
A name associated with bremelanotide, a melanocortin receptor agonist. Compounded PT-141 is not the FDA-approved product Vyleesi.
Educational overview
Research topic
Established evidenceGLP-1 Receptor Agonist | Metabolic Health
A GLP-1 receptor agonist with substantial human clinical evidence for specific approved indications. Compounded semaglutide is not FDA approved.
Educational overview
Research topic
Established evidenceDual GIP/GLP-1 Receptor Agonist | Metabolic Health
A dual GIP/GLP-1 receptor agonist evaluated in large randomized controlled trials. Compounded tirzepatide is not FDA approved.
Educational overview
Research topic
Investigational onlyInvestigational GIP/GLP-1/Glucagon Receptor Agonist | Metabolic Research
An investigational triple agonist in Phase 3 development. It is not FDA approved and should not be associated with a pharmacy-access or purchase action.
Educational overview
Research topic
Our standard
Products available through Kynorvia are not added to fill a catalog. Each featured product is evaluated through a rigorous review process: literature review, third-party testing standards, and clinical context — before it's made available here.
Learn about our curation process